Andrew J. Vickers, PhD
Financial Support: In part by funds from the Sidney Kimmel Center for Prostate and Urologic Cancers, a Specialized Programs of Research Excellence grant (P50-CA92629) from the National Cancer Institute to Dr. Howard Scher, and a National Institutes of Health/National Cancer Institute Cancer Center Support Grant (P30-CA008748) to Memorial Sloan Kettering Cancer Center.
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M17-2012.
Requests for Single Reprints: Andrew J. Vickers, PhD, Memorial Sloan Kettering Cancer Center, 485 Lexington Avenue, 2nd Floor, New York, NY 10065; e-mail, VickersA@mskcc.org.
Vickers AJ. Prostate Cancer Screening: Time to Question How to Optimize the Ratio of Benefits and Harms. Ann Intern Med. 2017;167:509–510. [Epub ahead of print 5 September 2017]. doi: https://doi.org/10.7326/M17-2012
Download citation file:
Published: Ann Intern Med. 2017;167(7):509-510.
Published at www.annals.org on 5 September 2017
Cancer Screening/Prevention, Hematology/Oncology, Prevention/Screening, Prostate Cancer.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use